Integration of machine learning and mechanistic models accurately predicts variation in cell density of glioblastoma using multiparametric MRI
暂无分享,去创建一个
Leland S. Hu | Teresa Wu | L. Baxter | K. Swanson | A. Hawkins-Daarud | J. R. Mitchell | J. Eschbacher | P. Nakaji | Kris A Smith | H. Yoon | A. Nespodzany | K. Singleton | P. Jackson | N. Gaw | Jing Li | Yanzhe Xu | Lujia Wang | A.C. Gonzales
[1] Jennie W. Taylor,et al. COMP-05. EVALUATION OF A DEEP LEARNING ARCHITECTURE FOR MRI PREDICTION OF IDH, 1p19q AND TERT IN GLIOMA PATIENTS , 2018, Neuro-Oncology.
[2] W. Qin,et al. Radiomics signature: A potential biomarker for the prediction of MGMT promoter methylation in glioblastoma , 2018, Journal of magnetic resonance imaging : JMRI.
[3] Wei Cao,et al. Deep Learning based Radiomics (DLR) and its usage in noninvasive IDH1 prediction for low grade glioma , 2017, Scientific Reports.
[4] N. Paragios,et al. Promises and challenges for the implementation of computational medical imaging (radiomics) in oncology , 2017, Annals of oncology : official journal of the European Society for Medical Oncology.
[5] Leland S. Hu,et al. Radiogenomics to characterize regional genetic heterogeneity in glioblastoma , 2016, Neuro-oncology.
[6] A. Madabhushi,et al. Radiomic features from the peritumoral brain parenchyma on treatment-naïve multi-parametric MR imaging predict long versus short-term survival in glioblastoma multiforme: Preliminary findings , 2017, European Radiology.
[7] Dewen Yang. Standardized MRI assessment of high-grade glioma response: a review of the essential elements and pitfalls of the RANO criteria. , 2016, Neuro-oncology practice.
[8] Paul Kinahan,et al. Radiomics: Images Are More than Pictures, They Are Data , 2015, Radiology.
[9] Teresa Wu,et al. Multi-Parametric MRI and Texture Analysis to Visualize Spatial Histologic Heterogeneity and Tumor Extent in Glioblastoma , 2015, PloS one.
[10] Naoya Hashimoto,et al. Immunotherapy response assessment in neuro-oncology: a report of the RANO working group. , 2015, The Lancet. Oncology.
[11] Juan J. Martinez,et al. Evaluation of tumor-derived MRI-texture features for discrimination of molecular subtypes and prediction of 12-month survival status in glioblastoma. , 2015, Medical physics.
[12] K. Swanson,et al. Patient-Specific Mathematical Neuro-Oncology: Using a Simple Proliferation and Invasion Tumor Model to Inform Clinical Practice , 2015, Bulletin of mathematical biology.
[13] Kristin R. Swanson,et al. Patient-Specific Metrics of Invasiveness Reveal Significant Prognostic Benefit of Resection in a Predictable Subset of Gliomas , 2014, PloS one.
[14] Peter Canoll,et al. MRI-localized biopsies reveal subtype-specific differences in molecular and cellular composition at the margins of glioblastoma , 2014, Proceedings of the National Academy of Sciences.
[15] David Basanta,et al. Invasion and proliferation kinetics in enhancing gliomas predict IDH1 mutation status. , 2014, Neuro-oncology.
[16] Kathleen Seidel,et al. 5-ALA complete resections go beyond MR contrast enhancement: shift corrected volumetric analysis of the extent of resection in surgery for glioblastoma , 2014, Acta Neurochirurgica.
[17] A. Jacobs,et al. Response to "reply to [18F]-fluoro-ethyl-L-tyrosine PET: a valuable diagnostic tool in neuro-oncology, but not all that glitters is glioma" by Hutterer et al. , 2013, Neuro-oncology.
[18] Kristin R. Swanson,et al. Response classification based on a minimal model of glioblastoma growth is prognostic for clinical outcomes and distinguishes progression from pseudoprogression. , 2013, Cancer research.
[19] Eugen Trinka,et al. [18F]-fluoro-ethyl-L-tyrosine PET: a valuable diagnostic tool in neuro-oncology, but not all that glitters is glioma. , 2013, Neuro-oncology.
[20] Kristin R. Swanson,et al. Discriminating Survival Outcomes in Patients with Glioblastoma Using a Simulation-Based, Patient-Specific Response Metric , 2013, PloS one.
[21] Andre Dekker,et al. Radiomics: the process and the challenges. , 2012, Magnetic resonance imaging.
[22] Benjamin M Ellingson,et al. Spatially quantifying microscopic tumor invasion and proliferation using a voxel‐wise solution to a glioma growth model and serial diffusion MRI , 2011, Magnetic resonance in medicine.
[23] J. Tonn,et al. FET-PET for malignant glioma treatment planning. , 2011, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.
[24] P. Wen,et al. Response Assessment in Neuro-Oncology , 2011, Current oncology reports.
[25] K Hendrickson,et al. Predicting the efficacy of radiotherapy in individual glioblastoma patients in vivo: a mathematical modeling approach , 2010, Physics in medicine and biology.
[26] Ru-Fang Yeh,et al. Glioblastoma multiforme regional genetic and cellular expression patterns: influence on anatomic and physiologic MR imaging. , 2010, Radiology.
[27] Albert Lai,et al. Prognostic significance of growth kinetics in newly diagnosed glioblastomas revealed by combining serial imaging with a novel biomathematical model. , 2009, Cancer research.
[28] A. Koch,et al. Association of F18-fluoro-ethyl-tyrosin uptake and 5-aminolevulinic acid-induced fluorescence in gliomas , 2009, Acta Neurochirurgica.
[29] Gargi Chakraborty,et al. Quantitative metrics of net proliferation and invasion link biological aggressiveness assessed by MRI with hypoxia assessed by FMISO-PET in newly diagnosed glioblastomas. , 2009, Cancer research.
[30] Christian Woiciechowsky,et al. Correlation of F-18-fluoro-ethyl-tyrosin uptake with vascular and cell density in non-contrast-enhancing gliomas , 2008, Journal of Neuro-Oncology.
[31] C. Decaestecker,et al. Apparent Diffusion Coefficient and Cerebral Blood Volume in Brain Gliomas: Relation to Tumor Cell Density and Tumor Microvessel Density Based on Stereotactic Biopsies , 2008, American Journal of Neuroradiology.
[32] K. Swanson,et al. A mathematical modelling tool for predicting survival of individual patients following resection of glioblastoma: a proof of principle , 2007, British Journal of Cancer.
[33] Hervé Delingette,et al. A Recursive Anisotropic Fast Marching Approach to Reaction Diffusion Equation: Application to Tumor Growth Modeling , 2007, IPMI.
[34] Kristin R. Swanson,et al. The Evolution of Mathematical Modeling of Glioma Proliferation and Invasion , 2007, Journal of neuropathology and experimental neurology.
[35] Mikhail Belkin,et al. Manifold Regularization: A Geometric Framework for Learning from Labeled and Unlabeled Examples , 2006, J. Mach. Learn. Res..
[36] Marko Robnik-Sikonja,et al. Theoretical and Empirical Analysis of ReliefF and RReliefF , 2003, Machine Learning.
[37] Usha Sinha,et al. Relationships Between Choline Magnetic Resonance Spectroscopy, Apparent Diffusion Coefficient and Quantitative Histopathology in Human Glioma , 2000, Journal of Neuro-Oncology.
[38] M. Westphal,et al. Cost of migration: invasion of malignant gliomas and implications for treatment. , 2003, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[39] D. Silbergeld,et al. Isolation and Characterization of Human Malignant Glioma Cells from Histologically Normal Brain , 1997 .